Hargreave Hale AIM VCT has invested in LabGenius Therapeutics, a drug discovery company combining high-throughput experimentation and machine learning (ML) to ...
Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results